폐암 환자의 항우울제 처방현황과 관련 요인 분석
An Analysis on Prescribing Patterns of Antidepressants and Their Associated Factors in Lung Cancer Patients
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: Depression is the leading cause of lowering the quality of life of cancer patients and lung cancer is the most likely to cause depression. It is necessary to find out depression-related factors in lung cancer patients. Methods: The study was a retrospective cohort study using medical records, and was a non-equivalent comparison group design. It involved patients diagnosed of lung cancer at the Konkuk University Medical Center from January to December 2012. Between antidepressants prescription group and non prescription group, socio-demographic factors, clinical factors, treatment-related factors and other factors were analyzed statistically. Results: Antidepressant prescription group consisted of 23 people and non-prescription group of 206 people. Prescription rate of quetiapine was the highest 47.8% (11/23), followed by escitalopram (43.5%, 10/23), amitriptyline and trazodone (30.4%, 7/23). The prescription group was prescribed with an average of 1.9 antidepressants. Antidepressants were prescribed after average of 248 days from lung cancer diagnosis and prescription period per patient was average 177.5 days. According to the result of univariate logistic regression analysis between 2 groups, factors such as number of outpatient visit, number of admission, days of hospitalization, sleep disorder, and comorbidity were found to be statistically significant (p < 0.05). However, According multivariate logistic regression analysis showed that number of admission, days of hospitalization and sleep disorder were statistically significant (p < 0.05) excluding comorbidity. Conclusion: About 10% of lung cancer patients had received a prescription for antidepressants after lung cancer diagnosis. A sleep disorder, number of hospitalization and length of stay were identified as factors influencing the prescribing antidepressants.
Abstract
Background: Depression is the leading cause of lowering the quality of life of cancer patients and lung cancer is the most likely to cause depression. It is necessary to find out depression-related factors in lung cancer patients. Methods: The study was a retrospective cohort study using medical records, and was a non-equivalent comparison group design. It involved patients diagnosed of lung cancer at the Konkuk University Medical Center from January to December 2012. Between antidepressants prescription group and non prescription group, socio-demographic factors, clinical factors, treatment-related factors and other factors were analyzed statistically. Results: Antidepressant prescription group consisted of 23 people and non-prescription group of 206 people. Prescription rate of quetiapine was the highest 47.8% (11/23), followed by escitalopram (43.5%, 10/23), amitriptyline and trazodone (30.4%, 7/23). The prescription group was prescribed with an average of 1.9 antidepressants. Antidepressants were prescribed after average of 248 days from lung cancer diagnosis and prescription period per patient was average 177.5 days. According to the result of univariate logistic regression analysis between 2 groups, factors such as number of outpatient visit, number of admission, days of hospitalization, sleep disorder, and comorbidity were found to be statistically significant (p < 0.05). However, According multivariate logistic regression analysis showed that number of admission, days of hospitalization and sleep disorder were statistically significant (p < 0.05) excluding comorbidity. Conclusion: About 10% of lung cancer patients had received a prescription for antidepressants after lung cancer diagnosis. A sleep disorder, number of hospitalization and length of stay were identified as factors influencing the prescribing antidepressants.
참고문헌 (30)
- "Statistics Korea"[URL]
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2012", Cancer Research and Treatment, 47(2), pp.127~141 (2015), 대한암학회[DOI]
- "National Cancer information center"[URL]
- Smith E, "Assessing the independent contribution to quality of life from anxiety and depression in patients with advanced cancer", Palliat Med, 17(6), pp.509~513 (2003)
- Mitchell AJ, "Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliativecare settings: a meta-analysis of 94 interview-based studies", The Lancet Oncol, 12(2), pp.160~174 (2011)
- Devlen J, "Psychological problems associated with diagnosis and treatment of lymphomas. I: retrospective study", Br Med J (Clin Res Ed), 295(6604), pp.953~ (1987)
- Massie MJ, "Prevalence of depression in patients with cancer", J Natl Cancer Inst Monogr, 32, pp.57~71 (2004)
- Çavu o lu H, "Depression in children with cancer", J Pediatr Nurs, 16(5), pp.380~385 (2001)
- Carlson LE, "Cancer distress screening: needs, models, and methods", J Psychosom Res, 55(5), pp.403~409 (2003)
- Goldzweig G, "Meeting expectations of patients with cancer: relationship between patient satisfaction, depression, and coping", J Clin Oncol, 28(9), pp.1560~1565 (2010)
- Pinquart M, "Depression and cancer mortality: a metaanalysis", Psychol Med, 40(11), pp.1797~1810 (2010)
- 이정림, "폐암환자의 스티그마, 디스트레스와 삶의 질의 관계", Asian Oncology Nursing, 11(3), pp.237~246 (2011), 대한종양간호학회
- Sellick SM, "Screening new cancer patients for psychological distress using the hospital anxiety and depression scale", Psycho-Oncology, 16(6), pp.534~542 (2007)
- Walker J, "Treatment of depression in people with lung cancer: a systematic review", Lung Cancer, 79(1), pp.46~53 (2013)
- "Anatomical-Therapeutic-Chemical-Classification-System. ATC/DDD Index 2013"[URL]
- Loy JW, "Sport and social systems: a guide to the analysis, problems, and literature" (1978), Addison-Wesley Reading
- DiMatteo MR, "Depression is a risk factor for noncompliance with medical treatmentmeta-analysis of the effects of anxiety and depression on patient adherence", Arch Intern Med, 160(14), pp.2101~2107 (2000)
- "Cancer Registration Statistics 2010"[URL]
- 임세원, "한국형 우울증 진료지침 개발및 적용연구-우울증 진료지침 개발의 국내외 현황과 개발방향-", 생물정신의학, 13(1), pp.11~18 (2006), 대한생물정신의학회
- Bauer M, "Prescribing patterns of antidepressants in Europe: results from the factors influencing depression endpoints research (FINDER) study", Eur Psychiatry, 23(1), pp.66~73 (2008)
- Park JH, "Prevalence of major depressive disorder and minor depressive disorder in an elderly Korean population: results from the Korean longitudinal study on health and aging (KLoSHA)", J Affect Disord, 125(1-3), pp.234~240 (2010)
- Djernes J, "Prevalence and predictors of depression in populations of elderly: a review", Acta Psychiatr Scand, 113(5), pp.372~387 (2006)
- Cataldo JK, "Measuring stigma in people with lung cancer: psychometric testing of the cataldo lung cancer stigma scale", Oncol Nurs Forum, 38(1), pp.E46~E54 (2011)
- Kitagawa R, "Depression increases the length of hospitalization for patients undergoing thoracic surgery: a preliminary study", Psychosomatics, 52(5), pp.428~432 (2011)
- Vena C, "Sleep-wake disturbances and quality of life in patients with advanced lung cancer", Oncol Nurs Forum, 33(4), pp.761~769 (2006)
- Hopwood P, "Depression in patients with lung cancer:prevalence and risk factors derived from quality-of-life data", J Clin Oncol, 18(4), pp.893~903 (2000)
- Tanaka K, "Factors correlated with dyspnea in advanced lung cancer patients: organic causes and what else?", J Pain Symptom Manage, 23(6), pp.490~500 (2002)
- Lee GH, "Effect of guided imagery program on patients depression and anxiety receiving cancer chemotherapy", J Korean Acad of Psychiatr Ment Health Nurs, 13(2), pp.125~134 (2004)
- Toh S, "Hernández-Díaz S. Use of antidepressants and risk of lung cancer", Cancer Causes Control, 18(10), pp.1055~1064 (2007)
- Sullivan DR, "Treatment receipt and outcomes among lung cancer patients with depression", Clin Oncol, 26(1), pp.25~31 (2014)